Opening book details…
Can I read Immunotherapy for Metastatic Melanoma on EtoBox?
Immunotherapy for Metastatic Melanoma by Christopher R. Zito; Harriet M. Kluger is a Biochemistry, Genetics and Molecular Biology article available to read on EtoBox.
What is Immunotherapy for Metastatic Melanoma about?
## Abstract Melanoma has traditionally been considered an immunogenic tumor. A number of approaches have been studied for enhancement of antitumor immunity. The first cytokine approved for the treatment of metastatic melanoma, interleukin‐2, has resulted in prolonged responses in a small subset of patients, providing hope that immunotherapy might be useful for this disease. Ipilimumab, a monoclonal antibody to CTLA‐4, was recently approved and a number of other promising investigational approaches are currently being pursued. This manuscript discusses more recent advances in the treatment of melanoma employing a variety of immune‐enhancing approaches. J. Cell. Biochem. 113: 725–734, 2012. © 2011 Wiley Periodicals, Inc.
Who reads Immunotherapy for Metastatic Melanoma?
It is typically read by researchers, students, and practitioners in Biochemistry, Genetics and Molecular Biology.
- Author
- Christopher R. Zito; Harriet M. Kluger
- Publisher
- John Wiley and Sons; Wiley (John Wiley & Sons); John Wiley & Sons Inc.; Wiley (ISSN 0730-2312)
- Published
- 2012
- Language
- EN
- Field
- Biochemistry, Genetics and Molecular Biology (Life Sciences)